A Study of HS-10353 in Adult Participants With Major Depressive Disorder

NCT05938179 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: HS-10353 30mg oral capsules
DRUG: HS-10353 50mg oral capsules
DRUG: Placebo for HS-10353 30mg capsules
DRUG: Placebo for HS-10353 50mg capsules

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.